FDA recall D-0003-2024
Central Admixture Pharmacy Services Inc · Class II · drug
Product
ePHEDrine in 0.9% sodium chloride, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, CAPS Inc., Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6004-1
Reason for recall
Lack of assurance of sterility:
Distribution
Nationwide in the USA
Key facts
- Status
- Terminated
- Initiation date
- 2023-09-21
- Report date
- 2023-10-11
- Termination date
- 2025-03-19
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- San Diego, CA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0003-2024